VYNE: מזומנים בחישוב למניה אחת vynetherapeutics.com

This free cash flow per share chart demonstrates the liquidity of VYNE Therapeutics (VYNE), where the 28.92 level captures the current state. The biopharma company utilizes unique MST technology to create fast-absorbing foam for psoriasis. The company plans to generate revenue through the implementation of innovative therapy methods for immuno-inflammatory pathologies. Stability of chemical raw material supplies is ensured via diversified routes and strict temperature control.
פילוחי מדדים מקיפים ואנליטיקה עבור VYNE Therapeutics Inc (VYNE)

Long-term investing requires strict liquidity control to minimize capital risks. Stable capacity utilization at VYNE (VYNE) for the production of dermatological agents necessitates constant financial support. This cash per share chart reflects the ratio of total cash balance to the number of issued securities. Growth in this indicator confirms the company's stability, although excess funds may reduce overall profitability. This metric determines the actual value of the liquid reserve on a per-share basis.